Browsing by Author "Muro, K."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemPembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma : results from the phase II nonrandomized KEYNOTE-059 study(2019) Bang, Y.J.; Kang, Y.K.; Catenacci, D.V.; Muro, K.; Fuchs, C.S.; Geva, R.; Hara, H.; Golan, T.; Garrido S., Marcelo; Jalal, S.I.; Borg, C.; Doi, T.; Yoon, H.H.; Savage, M.J.; Wang, J.; Dalal, R.P.; Shah, S.; Wainberg, Z.A.; Chung, H.C.
- ItemSafety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial(2018) Fuchs, C. S.; Doi, T.; Jang, R. W.; Muro, K.; Satoh, T.; Machado, M.; Sun, W.; Jalal, S. I.; Shah, M. A.; Garrido S., Marcelo; Metges, J. P.